CoagulationDisorders near Cape Coral, FL

Care Philosophy: Dr Haider is an Associate Member in the Department of Gastrointestinal Oncology at Moffitt Cancer Center and an Associate Professorof Oncologic Sciences at University of South Florida. Dr Haider received her Bachelor of Science as well as her Medical Degree at the University of Florida in Gainesville, FL. She completed an internship and residency in Internal Medicine at the University of Southern California in Los Angeles, CA followed by Hematology and Medical Oncology Fellowship at Moffitt Cancer Center - University of South Florida in Tampa, FL. Dr Haider's clinical practice is focused on neuroendocrine tumor (NET) oncology. As a member of the Endocrine Program Multidisciplinary team, she also treats paraganglioma and pheochromocytoma.

Biography: Dr. McCann is a Board-certified Gynecologic Oncologist with Florida Cancer Specialists and Research Institute in Palm Beach County. He specializes in the medical and surgical treatment of patients with ovarian, endometrial and cervical cancer, with a focus on the use of minimally invasive techniques. He has presented his research on innovations in Gynecologic Oncology Robotics and Robotic Surgery and Endometrial Cancer Staging Surgery at professional symposiums, and his work has been published in several peer-reviewed publications. Dr. McCann received his Doctor of Osteopathic Medicine degree from the University of New England and completed residency training in Obstetrics & Gynecology at Saint Francis Hospital in Hartford, CT. He was awarded the Galloway Fellowship in Gynecology Service at Memorial Sloan-Kettering Cancer Center in New York, NY and also completed a fellowship in Gynecology Oncology at Massachusetts General Hospital in Boston. After completing his fellowship training, Dr. McCann served as an Instructor in Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School Hospital and on the medical staff of Beth Israel Deaconess Medical Center, Boston, MA and other hospitals throughout New England. He joined Florida Cancer Specialists in 2022.

Care Philosophy: Dr Jonathan Strosberg is a professor at Moffitt Cancer Center specializing in the management of neuroendocrine malignancies. He is a graduate of Harvard University and Cornell University Medical College and completed his residency and fellowship training programs at Georgetown University Hospital and Moffitt Cancer Center. He leads Moffitt's Neuroendocrine Tumor Division and Department of Gastrointestinal Oncology Research Program. Dr Strosberg has published over 150 articles on the diagnosis and management of neuroendocrine malignancies, with first-author publications in the New England Journal of Medicine, Journal of Clinical Oncology, Annals of Oncology, Clinical Cancer Research and other major journals.

Care Philosophy: Dr Tanvetyanon is a medical oncologist with expertise in lung cancer, mesothelioma and thymic carcinoma. Services offered include a wide array of clinical trials, immunotherapy programs, and hyperthermic intraperitoneal chemotherapy (HIPEC) for malignant mesothelioma. In addition, Dr Tanvetyanon is experienced in managing abnormal findings from lung cancer screening. Dr Tanvetyanon is a health outcomes researcher as well as an epidemiologist. To date, he has published over 50 peer-review articles in medical journals including Journal of Clinical Oncology, Annals of Oncology, Head & Neck and Journal of Thoracic Oncology.

Care Philosophy: At Florida Cancer Specialists & Research Institute you will find experienced and compassionate doctors you can trust to treat your unique cancer. Our physicians share a passion for delivering exceptional and personalized care for all forms of cancer and blood disorders, close to home. From genetic screening to immunotherapies and access to clinical trials, our top-ranked cancer experts provide the newest and most advanced treatments available increasing cure rates and extending lives. No other community-based oncology practice in Florida matches the clinical trial opportunities we offer. The majority of new cancer drugs approved for use in the U.S. in recent years were studied in clinical trials with FCS participation, prior to approval. Every interaction is focused on each patient's experience and well-being to minimize disruption to daily life. Beginning with your first appointment, our dedicated FCS team provides expert guidance and support at every step of your cancer journey.

Care Philosophy: Dr Saeed is anAssociate Member in the Moffitt Malignant Hematology program. Heearned his MD at the University of Baghdad, College of Medicine, Iraq. He completed a post-doctoral fellowship at the University of Kentucky, College of Pharmacy, in Dr Abeer Al-Ghananeem's Lab. Dr Saeed completed an Internal Medicine Residency and Hematology and Medical Oncology Fellowship, and he served as Chief Fellow at the University of Kentucky. Prior to Moffitt,Dr Saeedpracticed at the University of Kentucky, where he was appointed as an Assistant Professor in the Department of Internal Medicine, Division of Hematology and Blood and Marrow Transplantation, College of Medicine.Dr Saeed specializes in treating blood cancers.